PubMed · 1997 · 520 citations · 11 references
MedicineGeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaBrain TumorsCancer CytogeneticsCancer GenomicsGlioblastomaOncogene MutationsCancer Mutation AnalysisChromosome 10Q LossDeletion MutationsGlioblastoma PathologyGlioblastoma Tumor BiologyHomozygous DeletionPten InactivationSomatic Mutations
Alterations of the PTEN gene occur in glioblastoma multiforme. To determine the frequency of PTEN alteration, 34 consecutive glioblastomas were studied in detail. Sequencing each of the nine exons amplified from tumor DNA revealed 11 mutations. Analysis of polymorphic markers within and surrounding the PTEN gene identified an additional four homozygous deletion mutations. Loss of heterozygosity (LOH) was observed in 25 of 34 (74%) cases. All mutations occurred in the presence of LOH. PTEN was mutated in 44% (15 of 34) of all glioblastomas studied and 60% (15 of 25) of tumors with LOH on 10q. Thus, PTEN appears to be the major target of inactivation on chromosome 10q in glioblastoma multiforme.
11
Jing Li, Clifford Yen, Danny Liaw et al. · Science · 1997 · 4.8K citations
CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.
Esther Schmidt, Koichi Ichimura, Guido Reifenberger et al. · PubMed · 1994 · 442 citations